Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
22,391,502
-
Share change
-
+777,706
-
Total reported value
-
$1,726,588,185
-
Put/Call ratio
-
88%
-
Price per share
-
$77.11
-
Number of holders
-
185
-
Value change
-
+$78,884,093
-
Number of buys
-
97
-
Number of sells
-
87
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q1 2015
As of 31 Mar 2015 LIGAND PHARMACEUTICALS INC - Common Stock (LGND) had 185 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 22,391,502 shares of stock of the company.
Largest 10 holders included BLAIR WILLIAM & CO/IL, BlackRock Fund Advisors, Knott David M, RS INVESTMENT MANAGEMENT CO LLC, Invesco Ltd., CARDINAL CAPITAL MANAGEMENT LLC /CT, VANGUARD GROUP INC, FMR LLC, STATE STREET CORP, and BlackRock Institutional Trust Company, N.A..
This table shows 185 institutional shareholders of the security as of 31 Mar 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.